Chronic obstructive pulmonary disease (COPD) is a lung disease characterised by chronic bronchitis, emphysema, and remodelling. Its prevalence is increasing worldwide, however there are few effective therapies, and none of the treatments currently available prevent the progression of the disease or target all of the hallmark features. The development and progression of COPD is heterogeneous, which has hampered the development of new therapies.
New drugs under development for COPD
Lo Bello, FedericaPrimo
Membro del Collaboration Group
;Coppolino, IreneMembro del Collaboration Group
;Caramori, GaetanoUltimo
Membro del Collaboration Group
2020-01-01
Abstract
Chronic obstructive pulmonary disease (COPD) is a lung disease characterised by chronic bronchitis, emphysema, and remodelling. Its prevalence is increasing worldwide, however there are few effective therapies, and none of the treatments currently available prevent the progression of the disease or target all of the hallmark features. The development and progression of COPD is heterogeneous, which has hampered the development of new therapies.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
